Earnings · Hong Kong stocks
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) earnings
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H published its quarterly report on 2026-08-19. The stock moved -15.45% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-08-19
- Result
- Bad / loss
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -9.63% | — |
| 3 days | -15.45% | — |
| 7 days | -12.76% | — |
| 14 days | -15.71% | — |
| 30 days | -8.64% | — |
Report history
Over the last 2 reports, EPS beat the consensus estimate in 0 of them. The stock rose in the 3 trading days after 0 of 2 reports (average -10.58%).
| Published | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|
| 2026-08-19 | 0.34 | -23.44% | -15.45% | -8.64% | -5.80% |
| 2025-10-27 | 0.20 | -3.63% | -5.71% | -6.83% | -1.58% |
The last 2 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.